Literature DB >> 9846704

Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.

H Akaishi1, K Takeda, T Kaisho, R Shineha, S Satomi, J Takeda, S Akira.   

Abstract

Stat3, a member of signal transducers and activators of transcription (STAT), is activated by a variety of cytokines. Recently, mice lacking Stat3 specifically in T cells have been generated and shown to be defective in IL-6-induced proliferation due to the impairment in IL-6-mediated prevention of apoptosis. In the present study, we show that Stat3-deficient T cells are partially defective in IL-2-induced proliferation. Stat3-deficient T cells show impaired IL-2-mediated IL-2 receptor (IL-2R) alpha chain expression. When Stat3-deficient T cells are stimulated with high-dose IL-2, these T cells express IL-2Ralpha and proliferate to similar extents as wild-type T cells. These demonstrate that Stat3 activation is required for efficient T cell proliferation by IL-2 through IL-2Ralpha induction. Taken together, these findings demonstrate that Stat3 activation in T cells is responsible for IL-2- and IL-6-induced proliferation through distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846704     DOI: 10.1093/intimm/10.11.1747

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  27 in total

Review 1.  Stat transcription factors in mammary gland development and tumorigenesis.

Authors:  C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 2.  What does Stat3 do?

Authors:  David E Levy; Chien-kuo Lee
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Changing the STATus quo in T helper cells.

Authors:  Gretta L Stritesky; Mark H Kaplan
Journal:  Transcription       Date:  2011-07

4.  An Inhibitory Role for the Transcription Factor Stat3 in Controlling IL-4 and Bcl6 Expression in Follicular Helper T Cells.

Authors:  Hao Wu; Lin-Lin Xu; Paulla Teuscher; Hong Liu; Mark H Kaplan; Alexander L Dent
Journal:  J Immunol       Date:  2015-07-17       Impact factor: 5.422

5.  Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells.

Authors:  Hye-Jin Son; Seung Hoon Lee; Seon-Yeong Lee; Eun-Kyung Kim; Eun-Ji Yang; Jae-Kyung Kim; Hyeon-Beom Seo; Sung-Hwan Park; Mi-La Cho
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

6.  STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus.

Authors:  Peng Li; Suman Mitra; Rosanne Spolski; Jangsuk Oh; Wei Liao; Zhonghui Tang; Fei Mo; Xingwang Li; Erin E West; Daniel Gromer; Jian-Xin Lin; Chengyu Liu; Yijun Ruan; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-24       Impact factor: 11.205

7.  A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.

Authors:  Andrea M Siegel; Jennifer Heimall; Alexandra F Freeman; Amy P Hsu; Erica Brittain; Jason M Brenchley; Daniel C Douek; Gary H Fahle; Jeffrey I Cohen; Steven M Holland; Joshua D Milner
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

8.  Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.

Authors:  Jesse Rowley; Archana Monie; Chien-Fu Hung; T-C Wu
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 9.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.

Authors:  Yihui Fan; Renfang Mao; Jianhua Yang
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

10.  STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.

Authors:  Matthew R Olson; Felipe Fortino Verdan; Matthew M Hufford; Alexander L Dent; Mark H Kaplan
Journal:  J Immunol       Date:  2016-03-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.